Realbotix Corp’s Onconetix Deal: Stock Volatility, Negative P/E, and a Digital Asset Future
Realbotix Corp’s latest move: acquisition of Onconetix, a negative P/E and CAD 0.295 share price—how the firm plans to grow in the digital‑asset, blockchain sector.
3 minutes to read






